Does low DHEA-S together with low morning cortisol suggest reduced adrenal steroid-output reserve?

The assessment of hypothalamic-pituitary-adrenal (HPA) axis integrity relies on biomarkers that capture both immediate secretory patterns and chronic stimulatory status. For a 51-year-old female, evaluating morning cortisol alongside age-adjusted dehydroepiandrosterone sulfate (DHEA-S) provides a highly sensitive window into adrenal output.

Mechanistic pathways

• ACTH Regulation: Chronic adrenocorticotropic hormone (ACTH) deficiency—central to secondary or central adrenal insufficiency—deprives the adrenal cortex of its primary trophic and stimulatory signals.
• Adrenocortical Atrophy: This lack of chronic ACTH drive impairs the zona fasciculata, decreasing morning cortisol synthesis. It simultaneously down-regulates the zona reticularis, leading to diminished DHEA-S production.

Clinical evidence and diagnostics

• Morning Cortisol: Early morning serum cortisol levels below 3 to 5 µg/dL reflect acute HPA axis hypoactivity and correlate strongly with subnormal peak cortisol responses on standard or low-dose dynamic ACTH stimulation tests.
• DHEA-S Stability: Because DHEA-S has a long circulating half-life and lacks significant diurnal variation, it serves as a stable, integrated marker of cumulative adrenal androgen capacity and chronic ACTH drive.
• Synergistic Interpretation: While morning cortisol reflects acute circadian output, low DHEA-S confirms a sustained reduction in secretory capacity. Combining these markers significantly increases the predictive probability of true HPA axis impairment.

Bottom line

• The dual finding of low DHEA-S and low morning cortisol strongly indicates a reduced adrenal steroid-output reserve, suggesting chronic HPA axis hypoactivity or secondary adrenal insufficiency that warrants formal confirmatory dynamic stimulation testing.